These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29202277)

  • 1. Optimizing clobazam treatment in patients with Lennox-Gastaut syndrome.
    Isojarvi J; Gidal BE; Chung S; Wechsler RT
    Epilepsy Behav; 2018 Jan; 78():149-154. PubMed ID: 29202277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experience.
    Wheless JW; Isojarvi J; Lee D; Drummond R; Benbadis SR
    Epilepsy Behav; 2014 Dec; 41():47-52. PubMed ID: 25282105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years.
    Conry JA; Ng YT; Kernitsky L; Mitchell WG; Veidemanis R; Drummond R; Isojarvi J; Lee D; Paolicchi JM;
    Epilepsia; 2014 Apr; 55(4):558-67. PubMed ID: 24580023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clobazam is equally safe and efficacious for seizures associated with Lennox-Gastaut syndrome across different age groups: Post hoc analyses of short- and long-term clinical trial results.
    Ng YT; Conry J; Mitchell WG; Buchhalter J; Isojarvi J; Lee D; Drummond R; Chung S
    Epilepsy Behav; 2015 May; 46():221-6. PubMed ID: 25940107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome.
    Nabbout R; Arzimanoglou A; Auvin S; Berquin P; Desurkar A; Fuller D; Nortvedt C; Pulitano P; Rosati A; Soto V; Villanueva V; Cross JH
    Seizure; 2023 Aug; 110():78-85. PubMed ID: 37331197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Effects of Clobazam on Seizure Control and Quality of Life in Children With Lennox-Gastaut Syndrome: A Pilot Study.
    Weinstock A; Agarwal N; Farooq O; Cheema Z; Hamilton D; Parrish J
    J Child Neurol; 2019 Jul; 34(8):432-439. PubMed ID: 30913948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome.
    Ng YT; Conry JA; Drummond R; Stolle J; Weinberg MA;
    Neurology; 2011 Oct; 77(15):1473-81. PubMed ID: 21956725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clobazam and Aggression-Related Adverse Events in Pediatric Patients With Lennox-Gastaut Syndrome.
    Paolicchi JM; Ross G; Lee D; Drummond R; Isojarvi J
    Pediatr Neurol; 2015 Oct; 53(4):338-42. PubMed ID: 26245776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
    Thiele EA; Marsh ED; French JA; Mazurkiewicz-Beldzinska M; Benbadis SR; Joshi C; Lyons PD; Taylor A; Roberts C; Sommerville K;
    Lancet; 2018 Mar; 391(10125):1085-1096. PubMed ID: 29395273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deconstructing tolerance with clobazam: Post hoc analyses from an open-label extension study.
    Gidal BE; Wechsler RT; Sankar R; Montouris GD; White HS; Cloyd JC; Kane MC; Peng G; Tworek DM; Shen V; Isojarvi J
    Neurology; 2016 Oct; 87(17):1806-1812. PubMed ID: 27683846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clobazam-treated patients with Lennox-Gastaut syndrome experienced fewer seizure-related injuries than placebo patients during trial OV-1012.
    Isojarvi J; Lee D; Peng G; Sperling MR
    Epilepsia; 2016 Jun; 57(6):e113-6. PubMed ID: 27145465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study.
    Knupp KG; Scheffer IE; Ceulemans B; Sullivan J; Nickels KC; Lagae L; Guerrini R; Zuberi SM; Nabbout R; Riney K; Agarwal A; Lock M; Dai D; Farfel GM; Galer BS; Gammaitoni AR; Polega S; Davis R; Gil-Nagel A
    Epilepsia; 2023 Jan; 64(1):139-151. PubMed ID: 36196777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of clobazam tablets and film (AQST-120) for the treatment of Lennox-Gastaut syndrome.
    Besag FMC; Vasey MJ
    Expert Opin Pharmacother; 2019 Sep; 20(13):1563-1574. PubMed ID: 31373526
    [No Abstract]   [Full Text] [Related]  

  • 14. Is adjunctive Cannabidiol effective in controlling seizures for adult patients with Lennox-Gastaut Syndrome? - A single centre long term follow up study.
    Elbadri M; Bose S; Elkider M; Hayton T; McCorry D; Sumangala S; Wysota B; Samarasekera S
    Epilepsy Behav; 2024 Aug; 157():109904. PubMed ID: 38908033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term and long-term efficacy and safety of antiseizure medications in Lennox Gastaut syndrome: A network meta-analysis.
    Devi N; Madaan P; Ameen R; Sahu JK; Bansal D
    Seizure; 2022 Jul; 99():164-175. PubMed ID: 35487871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budget impact analysis of antiepileptic drugs for Lennox-Gastaut syndrome.
    Skornicki M; Clements KM; O'Sullivan AK
    J Manag Care Spec Pharm; 2014 Apr; 20(4):400-6. PubMed ID: 24684645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal-related adverse events from clinical trials of clobazam in Lennox-Gastaut syndrome.
    Tolbert D; Harris SI; Bekersky I; Lee D; Isojarvi J
    Epilepsy Behav; 2014 Aug; 37():11-5. PubMed ID: 24949576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial.
    Ohtsuka Y; Yoshinaga H; Shirasaka Y; Takayama R; Takano H; Iyoda K
    Epilepsy Res; 2016 Mar; 121():1-7. PubMed ID: 26827266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.
    Cramer JA; Sapin C; François C
    Acta Neurol Scand; 2013 Aug; 128(2):91-9. PubMed ID: 23410109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials.
    Gunning B; Mazurkiewicz-Bełdzińska M; Chin RFM; Bhathal H; Nortvedt C; Dunayevich E; Checketts D
    Acta Neurol Scand; 2021 Feb; 143(2):154-163. PubMed ID: 32969022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.